RENOVORX
RenovoRx is a developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. RenovoRx received FDA clearance for the RenovoCath™ RC120 and is currently introducing this innovative technology to the clinical market. RenovoRx has a motivated Management Team with broad experience and an exciting vision for the future of targeted delivery. The company also has a broad Advisory Board of intervention... al radiologists, surgical oncologists and gastroenterologists that guide the company's clinical development strategies. RenovoRx is backed by a strong Board of Directors committed to long-term, continuous support of the company, whose members provide critical expertise in the medical and biotechnology industry and the visionary thinking to succeed.
RENOVORX
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2009-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.renovorx.com
Total Employee:
1+
Status:
Active
Contact:
650-284-4433
Email Addresses:
[email protected]
Total Funding:
10.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Boston Scientific
Boston Scientific investment in Series D - RenovoRx
Astia Angels
Astia Angels investment in Series D - RenovoRx
btov Partners
btov Partners investment in Series D - RenovoRx
Golden Seeds
Golden Seeds investment in Series D - RenovoRx
Portfolia
Portfolia investment in Series A - RenovoRx
Barbara Clarke
Barbara Clarke investment in Series A - RenovoRx
Plug and Play
Plug and Play investment in Series C - RenovoRx
Next Wave/Portfolia Angel Fund
Next Wave/Portfolia Angel Fund investment in Series C - RenovoRx
Golden Seeds
Golden Seeds investment in Series C - RenovoRx
Astia Angels
Astia Angels investment in Series C - RenovoRx
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | RenovoRx Appoints James Ahlers as Chief Financial Officer |
Official Site Inspections
http://www.renovorx.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.05 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
